BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 28736128)

  • 1. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
    Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
    J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability.
    Izgelov D; Cherniakov I; Aldouby Bier G; Domb AJ; Hoffman A
    Mol Pharm; 2018 Apr; 15(4):1548-1555. PubMed ID: 29537855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
    Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
    Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of piperine on oral absorption of cannabidiol following acute vs. chronic administration.
    Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2020 May; 148():105313. PubMed ID: 32198013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.
    Jin X; Zhang ZH; Sun E; Tan XB; Li SL; Cheng XD; You M; Jia XB
    Int J Nanomedicine; 2013; 8():641-52. PubMed ID: 23426652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control.
    Ren T; Hu M; Cheng Y; Shek TL; Xiao M; Ho NJ; Zhang C; Leung SSY; Zuo Z
    Eur J Pharm Sci; 2019 Sep; 137():104988. PubMed ID: 31291598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin bioavailability from oil in water nano-emulsions: In vitro and in vivo study on the dimensional, compositional and interactional dependence.
    Vecchione R; Quagliariello V; Calabria D; Calcagno V; De Luca E; Iaffaioli RV; Netti PA
    J Control Release; 2016 Jul; 233():88-100. PubMed ID: 27155364
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats.
    Suresh D; Srinivasan K
    Indian J Med Res; 2010 May; 131():682-91. PubMed ID: 20516541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats.
    Izgelov D; Shmoeli E; Domb AJ; Hoffman A
    Int J Pharm; 2020 Apr; 580():119201. PubMed ID: 32147493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Self-Nanoemulsifying Drug Delivery Systems (Bio-SNEDDS) for Combined Oral Delivery of Curcumin and Piperine.
    Kazi M; Shahba AA; Alrashoud S; Alwadei M; Sherif AY; Alanazi FK
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32276393
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of interfacial composition on uptake of curcumin-piperine mixtures in oil in water emulsions by Caco-2 cells.
    Gülseren İ; Guri A; Corredig M
    Food Funct; 2014 Jun; 5(6):1218-23. PubMed ID: 24710007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Oral Bioavailability of Domperidone with Piperine in Male Wistar Rats: Involvement of CYP3A1 and P-gp Inhibition.
    Athukuri BL; Neerati P
    J Pharm Pharm Sci; 2017; 20():28-37. PubMed ID: 28459658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine.
    Ashour EA; Majumdar S; Alsheteli A; Alshehri S; Alsulays B; Feng X; Gryczke A; Kolter K; Langley N; Repka MA
    J Pharm Pharmacol; 2016 Aug; 68(8):989-98. PubMed ID: 27283755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
    Yu D; Kan Z; Shan F; Zang J; Zhou J
    Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis.
    Bhalekar MR; Madgulkar AR; Desale PS; Marium G
    Drug Dev Ind Pharm; 2017 Jun; 43(6):1003-1010. PubMed ID: 28161984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of piperine on the intestinal permeability and pharmacokinetics of linarin in rats.
    Feng X; Liu Y; Wang X; Di X
    Molecules; 2014 Apr; 19(5):5624-33. PubMed ID: 24786847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on the bioavailability, bio-efficacies and novel delivery systems for piperine.
    Zhang W; Zheng Q; Song M; Xiao J; Cao Y; Huang Q; Ho CT; Lu M
    Food Funct; 2021 Oct; 12(19):8867-8881. PubMed ID: 34528635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperine fast disintegrating tablets comprising sustained-release matrix pellets with enhanced bioavailability: formulation,
    Zhu Y; Yu J; Zhou G; Gu Z; Adu-Frimpong M; Deng W; Yu J; Xu X
    Pharm Dev Technol; 2020 Jun; 25(5):617-624. PubMed ID: 32009511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.